March 12, 2015

MBI’s Bobby Bringi inducted into engineering elite for biobased innovations, leadership

Bobby Bringi, President & CEO

The American Institute for Medical and Biological Engineering (AIMBE) will honor Bringi at March 16 ceremony in Washington, D.C.

LANSING, Mich. — The American Institute for Medical and Biological Engineering (AIMBE) will induct Bobby Bringi, Ph.D., who is CEO of MBI (Michigan Biotechnology Institute), to its College of Fellows at a March 16 ceremony in Washington, D.C. The College of Fellows is comprised of the top 2 percent of medical and biological engineers in the country.

Dr. Bringi was elected by peers and members of the College of Fellows for “the development of plant cell fermentation process to make taxol and leadership of Michigan Biotechnology Institute.” MBI — a Lansing, Michigan-based not-for-profit biotech accelerator and a wholly owned subsidiary of the Michigan State University Foundation — is pioneering the AFEX technology platform, a game-changing solution to the world’s grand challenge of feeding 9 billion people by the year 2050.

Read more